(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.81%) $81.27
(-1.76%) $1.956
(-0.03%) $2 302.20
(-0.15%) $26.62
(-0.34%) $945.00
(0.05%) $0.938
(0.20%) $11.12
(0.05%) $0.801
(0.00%) $93.45
1.98% ¥ 1 032.00
Live Chart Being Loaded With Signals
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system...
Stats | |
---|---|
Dagens volum | 31 800.00 |
Gjennomsnittsvolum | 96 166.00 |
Markedsverdi | 26.47B |
EPS | ¥19.18 ( 2024-02-13 ) |
Neste inntjeningsdato | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥4.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 24.99 |
ATR14 | ¥1.436 (0.14%) |
Volum Korrelasjon
FINDEX Inc. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
FINDEX Inc. Korrelasjon - Valuta/Råvare
FINDEX Inc. Økonomi
Annual | 2023 |
Omsetning: | ¥5.19B |
Bruttogevinst: | ¥3.33B (64.13 %) |
EPS: | ¥41.31 |
FY | 2023 |
Omsetning: | ¥5.19B |
Bruttogevinst: | ¥3.33B (64.13 %) |
EPS: | ¥41.31 |
FY | 2022 |
Omsetning: | ¥4.54B |
Bruttogevinst: | ¥2.72B (59.96 %) |
EPS: | ¥28.21 |
FY | 2021 |
Omsetning: | ¥4.97B |
Bruttogevinst: | ¥2.56B (51.45 %) |
EPS: | ¥20.24 |
Financial Reports:
No articles found.
FINDEX Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥6.50 (N/A) |
¥0 (N/A) |
¥4.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥0.250 | 2011-12-28 |
Last Dividend | ¥4.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 23 | -- |
Total Paid Out | ¥74.42 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.55 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.23 | |
Div. Directional Score | 7.74 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3245.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
2270.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9763.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
8842.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
7987.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7222.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6462.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5482.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
4471.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3657.T | Ex Dividend Junior | 2024-01-30 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.204 | 1.500 | 5.92 | 8.88 | [0 - 0.5] |
returnOnAssetsTTM | 0.178 | 1.200 | 4.05 | 4.86 | [0 - 0.3] |
returnOnEquityTTM | 0.243 | 1.500 | 8.41 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 6.48 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 5.97 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.32 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0558 | -1.500 | 9.07 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 2 394.51 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 6.53 | [0 - 30] |
freeCashFlowPerShareTTM | 20.20 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0685 | -1.500 | 9.73 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.641 | 1.000 | 2.64 | 2.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.288 | 1.000 | 6.23 | 6.23 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.564 | 1.000 | 2.42 | 2.42 | [0.2 - 2] |
assetTurnoverTTM | 0.875 | 0.800 | 7.50 | 6.00 | [0.5 - 2] |
Total Score | 11.26 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.89 | 1.000 | 7.59 | 0 | [1 - 100] |
returnOnEquityTTM | 0.243 | 2.50 | 8.98 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.265 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 6.53 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.835 | 1.500 | 1.101 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0998 | 1.000 | -0.00558 | 0 | [0.1 - 0.5] |
Total Score | 4.23 |
FINDEX Inc.
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.